Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIVOT: Virtual Support and Semaglutide for Obesity in Advanced Kidney Disease
NCT07858331Phase 4Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07858331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07858331.